Skip Navigation

ACS is committed to helping combat the global COVID-19 pandemic with initiatives and free resources. Learn More

2020 Drug Design and Delivery Symposium

We are planning a diverse set of broadcasts for this year’s symposium and will feature the most innovative and revolutionary ideas in drug design and delivery. The details for upcoming broadcasts will be posted as they are finalized. 

Mar
19
Passive Permeability: An Important Mechanism for Drug Absorption
Li Di - Pfizer
Faraj Atassi - AstraZeneca
Apr 15 COVID-19: A Groundwork for Therapeutic Agents and Vaccines
Qiongqiong Angela Zhou - CAS
Dennis Liotta - Emory Institute for Drug Development
Apr
30
How Drugs Really Get Into Cells: Why Passive Bilayer Diffusion is a Myth
Douglas Kell - University of Liverpool
Mike Sinz - Bristol-Myers Squibb
May
28
mRNA Technology for Infectious Diseases: Therapeutic Applications and Vaccine Development
Jim Thompson - Moderna, Inc.
Venkat Krishnamurthy - Astrazeneca
Jun
25
Enabling Technologies for Revealing Druggable Paths in RNA Biology
Amanda Garner - University of Michigan
Matt Disney - The Scripps Research Institute
Jul
30

Nature’s Dirty Little Secret: The Diverted Total Syntheses of Rhizosphere Natural Products as Targeted Antibacterial Agents
Bill Wuest - Emory University
Cassandra Quave - Emory University School of Medicine

Aug No Live Broadcast
Sep
23
Mitragyna Speciosa: What Science is Telling Us about Kratom
Christopher McCurdy - College of Pharmacy, University of Florida
Amy Newman - NIDA-Intramural Research Program, National Institutes of Health
Oct
29
DDDS7

Nov
19
DDDS8

ACS Webinars

MEET THE ORGANIZERS

Annette Bak
AstraZeneca

Lorraine Clark
ACS Publications


Patrice L. Jackson-Ayotunde 
Univ. of Maryland Eastern Shore 

Anirban Mahapatra
ACS Publications

Nicholas Meanwell
Bristol-Myers Squibb

John Morrison
Bristol-Myers Squibb

Nurulain Zaveri
Astraea Therapeutics

CO-PRODUCED BY

AAPS